MXPA05001469A - Use of fermented wheat germ extract as anti-inflammatory agent. - Google Patents
Use of fermented wheat germ extract as anti-inflammatory agent.Info
- Publication number
- MXPA05001469A MXPA05001469A MXPA05001469A MXPA05001469A MXPA05001469A MX PA05001469 A MXPA05001469 A MX PA05001469A MX PA05001469 A MXPA05001469 A MX PA05001469A MX PA05001469 A MXPA05001469 A MX PA05001469A MX PA05001469 A MXPA05001469 A MX PA05001469A
- Authority
- MX
- Mexico
- Prior art keywords
- wheat germ
- inflammatory agent
- germ extract
- fermented wheat
- avemar
- Prior art date
Links
- 241000209140 Triticum Species 0.000 title abstract 2
- 235000021307 Triticum Nutrition 0.000 title abstract 2
- 239000002260 anti-inflammatory agent Substances 0.000 title abstract 2
- 229940121363 anti-inflammatory agent Drugs 0.000 title abstract 2
- 239000000284 extract Substances 0.000 title abstract 2
- 239000010205 Avemar Substances 0.000 abstract 2
- 206010003246 arthritis Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to a new therapeutic use of a fermented wheat germ extract under the trade name Avemar(R), more specifically to use of Avemar(R) for the manufacture of a medicament useful as anti-inflammatory agent for preventing or treating or alleviating inflammatory conditions, particularly arthritis.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0202638A HUP0202638A3 (en) | 2002-08-09 | 2002-08-09 | Use of fermented wheat-germ extract for preparation of antiphlogistic compositions |
| PCT/HU2003/000065 WO2004014406A1 (en) | 2002-08-09 | 2003-08-08 | Use of fermented wheat germ extract as anti-inflammatory agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05001469A true MXPA05001469A (en) | 2005-06-06 |
Family
ID=89980690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05001469A MXPA05001469A (en) | 2002-08-09 | 2003-08-08 | Use of fermented wheat germ extract as anti-inflammatory agent. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1536809A1 (en) |
| JP (1) | JP2006501214A (en) |
| KR (1) | KR20050059066A (en) |
| CN (1) | CN1674924A (en) |
| AU (1) | AU2003255854A1 (en) |
| BR (1) | BR0313589A (en) |
| CA (1) | CA2494744A1 (en) |
| EA (1) | EA007844B1 (en) |
| HR (1) | HRP20050114A2 (en) |
| HU (1) | HUP0202638A3 (en) |
| IL (1) | IL166732A0 (en) |
| MX (1) | MXPA05001469A (en) |
| NO (1) | NO20051168L (en) |
| PL (1) | PL375391A1 (en) |
| WO (1) | WO2004014406A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2908998A1 (en) * | 2006-11-24 | 2008-05-30 | Bao Quoc Ho | Use of enzyme concentrate from cereal germ for therapeutic purposes to manufacture an anti inflammatory drug to treat arthritis and osteoarthritis |
| HUP0900614A2 (en) | 2009-09-29 | 2011-05-30 | Mate Dr Hidvegi | Preparation comprising dehydrated, fermented material with amorphous crystaline structure and process for its production |
| WO2010135580A2 (en) * | 2009-05-20 | 2010-11-25 | The Regents Of The University Of California | Fermented wheat germ proteins (fwgp) for the treatment of cancer |
| US20120164132A1 (en) * | 2010-08-02 | 2012-06-28 | Mate Hidvegi | Anticancer and immunomodulating molecules and fractions containing said molecules, and process for preparing said fractions and said molecules from fermented vegetal material, and their uses |
| GB201108560D0 (en) | 2011-05-20 | 2011-07-06 | 3 Ch Ltd | Use of fermented wheat germ in the treatment of inflammatory bowel disease |
| GB201110746D0 (en) | 2011-06-23 | 2011-08-10 | Biropharma Uk Ltd | Wheat germ derived material |
| JP6115995B2 (en) * | 2013-04-24 | 2017-04-19 | 株式会社日清製粉グループ本社 | Non-enzymatic saccharification reaction inhibitor |
| CN104381450A (en) * | 2014-10-15 | 2015-03-04 | 张士远 | Health milk for treatment of gastric mucosal injury and preparation method thereof |
| WO2017196048A1 (en) * | 2016-05-11 | 2017-11-16 | 씨제이제일제당 (주) | Externally applied composition for alleviating skin wrinkles, containing extract of fermented wheat germ product as active ingredient |
| WO2018056600A1 (en) * | 2016-09-23 | 2018-03-29 | 씨제이제일제당 (주) | Topical composition, for soothing skin, containing fermented wheat germ extract as active ingredient |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07242537A (en) * | 1994-03-04 | 1995-09-19 | Kibun Foods Inc | Production of substance having anti-inflammatory activity and anti-inflammatory agent |
| JPH08337536A (en) * | 1995-06-14 | 1996-12-24 | Asahi Breweries Ltd | Agent for antiactive oxygen, antiactive oxygen agent, cosmetic, food and medicine containing the same as active ingredient |
| HU223344B1 (en) * | 1997-08-13 | 2004-06-28 | Máté Hidvégi | Immunostimulant and metastasis-inhibiting fermented dried material, pharmaceutical compositions containing same, process for its production and its uses |
-
2002
- 2002-08-09 HU HU0202638A patent/HUP0202638A3/en unknown
-
2003
- 2003-08-08 CN CNA038189003A patent/CN1674924A/en active Pending
- 2003-08-08 BR BR0313589-6A patent/BR0313589A/en not_active Application Discontinuation
- 2003-08-08 KR KR1020057002283A patent/KR20050059066A/en not_active Application Discontinuation
- 2003-08-08 JP JP2004527076A patent/JP2006501214A/en active Pending
- 2003-08-08 PL PL03375391A patent/PL375391A1/en not_active Application Discontinuation
- 2003-08-08 EP EP03784303A patent/EP1536809A1/en not_active Withdrawn
- 2003-08-08 MX MXPA05001469A patent/MXPA05001469A/en unknown
- 2003-08-08 WO PCT/HU2003/000065 patent/WO2004014406A1/en not_active Application Discontinuation
- 2003-08-08 EA EA200500326A patent/EA007844B1/en not_active IP Right Cessation
- 2003-08-08 AU AU2003255854A patent/AU2003255854A1/en not_active Abandoned
- 2003-08-08 CA CA002494744A patent/CA2494744A1/en not_active Abandoned
-
2005
- 2005-02-03 HR HR20050114A patent/HRP20050114A2/en not_active Application Discontinuation
- 2005-02-07 IL IL16673205A patent/IL166732A0/en unknown
- 2005-03-04 NO NO20051168A patent/NO20051168L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006501214A (en) | 2006-01-12 |
| EA200500326A1 (en) | 2005-06-30 |
| NO20051168L (en) | 2005-03-04 |
| AU2003255854A1 (en) | 2004-02-25 |
| HU0202638D0 (en) | 2002-10-28 |
| HRP20050114A2 (en) | 2005-10-31 |
| EA007844B1 (en) | 2007-02-27 |
| HUP0202638A2 (en) | 2004-06-28 |
| CN1674924A (en) | 2005-09-28 |
| HUP0202638A3 (en) | 2007-08-28 |
| PL375391A1 (en) | 2005-11-28 |
| WO2004014406A1 (en) | 2004-02-19 |
| IL166732A0 (en) | 2006-01-15 |
| BR0313589A (en) | 2005-07-12 |
| CA2494744A1 (en) | 2004-02-19 |
| KR20050059066A (en) | 2005-06-17 |
| EP1536809A1 (en) | 2005-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
| MY148480A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| GEP20104994B (en) | Tetrahydroindolone and tetrahydroindazolone derivatives | |
| IL187328A (en) | N-methyl-2-fluoro-{4-[3-(4-cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxo-imidazolidin-1-yl]}benzamide, pharmaceutical compositions comprising the same and uses thereof in the manufacture of medicaments | |
| MX2009006742A (en) | Novel compounds. | |
| MXPA03011515A (en) | Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents. | |
| MXPA04004842A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. | |
| MXPA04004837A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. | |
| NO20055863L (en) | W-carboxyaryl-substituted diphenylurea compounds as raf kinase inhibitors | |
| IL161154A0 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| TW200621765A (en) | Substituted phenylaminothiazoles and their use | |
| WO2008024497A3 (en) | INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE TYPE 1 | |
| DE602004011394D1 (en) | Thiazolderivate | |
| IL172773A0 (en) | Formulations for the treatment of arhritis conditions | |
| TW200509937A (en) | Novel compounds and their use in therapy | |
| NO20051168L (en) | Use of fermented wheat germ extract as anti-inflammatory agent | |
| EP1831239B8 (en) | A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| WO2003106450A8 (en) | Phenylaminopyrimidines and their use as rho-kinase inhibitors | |
| UA86399C2 (en) | Normal;heading 1;heading 2;USE OF 2,5-DIHYDROXYBENZENESULPHONIC ACID IN THE PRODUCTION OF MEDICAMENTS FOR THE TREATMENT OF ANGIODEPENDENT DISEASES | |
| TW200621703A (en) | Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
| SI1594885T1 (en) | Medicament for inhibiting tumour growth | |
| RS44204A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| IL163951A (en) | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
| GB0229081D0 (en) | Multifunctional cationic photoinitiators, their preparation and use |